Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion type Assertion NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_head.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion description "[Vemurafenib and dabrafenib, two potent tyrosine kinase inhibitors (TKIs) of the BRAF(V600E) kinase, are highly effective in the treatment of a BRAF (V600) -mutant metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_provenance.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion evidence source_evidence_literature NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_provenance.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion SIO_000772 26601866 NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_provenance.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion wasDerivedFrom befree-2016 NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_provenance.
- NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_assertion wasGeneratedBy ECO_0000203 NP1295627.RAvpw8oi5RAKLp9_3HY5V2H6HE609ZWgAq38eCMbPHwZQ130_provenance.